Septerna (SEPN) Non-Current Assets (2023 - 2026)
Septerna (SEPN) recorded quarterly Non-Current Assets of $201.6 million in Q1 2026, up 8.86% quarter-over-quarter from $185.2 million in Q4 2025, and up 120.24% on a YoY basis from $91.6 million in Q1 2025.
Septerna (SEPN) Non-Current Assets (2023 - 2026) Analysis & Trends
Septerna's Non-Current Assets history runs 4 years deep, the most recent figure standing at $201.6 million for Q1 2026.
- In Q1 2026, Non-Current Assets rose 120.24% year-over-year to $201.6 million; the TTM figure through Mar 2026 stood at $582.9 million (up 132.85% YoY), while the FY2025 annual figure was $185.2 million, up 85.72% from the prior year.
- Non-Current Assets was $201.6 million for Q1 2026 at Septerna, up from $185.2 million in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $201.6 million in Q1 2026 to a low of $18.2 million in Q4 2023.
- Historically, Non-Current Assets has averaged $104.2 million across 4 years, with a median of $95.6 million in 2024.
- The sharpest annual moves came in 2024 and 2025: Non-Current Assets surged 448.3% in 2024, then soared 85.72% in 2025.
- A 4-year view of Non-Current Assets shows it stood at $18.2 million in 2023, then soared by 448.3% to $99.7 million in 2024, then jumped by 85.72% to $185.2 million in 2025, then advanced by 8.86% to $201.6 million in 2026.
- The last three Non-Current Assets figures came in at $201.6 million (Q1 2026), $185.2 million (Q4 2025), and $115.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 62,953.78 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 289.41 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 4.56 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 486.60 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 30.30 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 5.18 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 14.75 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 39.71 Mn |
| 10 | Septerna | 1.62 Bn | 1.62 Bn | - | 201.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 201.63 Mn |
| Dec 31, 2025 | 185.22 Mn |
| Sep 30, 2025 | 114.97 Mn |
| Jun 30, 2025 | 81.09 Mn |
| Mar 31, 2025 | 91.55 Mn |
| Dec 31, 2024 | 99.73 Mn |
| Sep 30, 2024 | 40.87 Mn |
| Dec 31, 2023 | 18.19 Mn |